Brazil’s Agência Nacional de Vigilância Sanitária – a.k.a. National Sanitary Surveillance Agency (ANVISA) – is anticipated to vote subsequent week on two draft resolutions which could have sweeping ramifications for the healthcare cannabis sector.

If authorized, the proposals would for the initial time regulate the domestic cultivation of healthcare cannabis in Brazil and build a framework to let the registration of marijuana-primarily based medicines with out completed clinical trials.

Producers would be capable to sell their harvested crops only to investigation institutions or to suppliers of registered cannabis-primarily based medicines. Sales to folks, wholesalers or pharmacies would stay prohibited.

The agency received far more than 1,000 submissions on the proposals by way of the 60-day comment period ending Aug. 19.

Considering the fact that then, authorities have been processing the feedback.

A vote on the final text is set to take place Tuesday. Approval calls for a easy majority of the agency’s 5 directors.

ANVISA’s move received heavy opposition from numerous higher-level government authorities.

As reported by Folha de S. Paulo, the proposals face resistance from inside the wellness regulatory physique.

A single of the 5 directors was appointed in August by President Jair Bolsonaro, and he expressed issues about enabling domestic cultivation.

Present Director-President Wililam Dib, who is a supporter of the proposals, will finish his term in December.

His successor could be closer to the Bolsonaro government’s position, signalling that sentiment from inside ANVISA might turn against the regulations.

Yet another of the 5 directors will also be replaced by Bolsonaro in December.

When the vote is anticipated Tuesday, there’s danger of delay if a single of the directors justifies a have to have for far more time to evaluate the proposals.

Delaying the vote till immediately after December would imply that the majority of the directors of the agency will be Bolsonaro appointees.

In an interview with Folha, Dib mentioned that the final proposals will be just about the very same as these initially proposed.

The director-president admitted he received stress from the government  to not regulate cultivation, but also that he is optimistic about the proposals getting authorized.

Presently, Brazil has a restrictive import-only plan.

A lot more than 10,000 authorizations have been granted considering that the starting of the plan, and there are presently about five,000 active individuals.

Alfredo Pascual can be reached at [email protected]